Atreca Inc (BCEL)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
John A. Orwin
Employees:
130
500 SAGINAW DRIVE, FIRST FLOOR, REDWOOD CITY, CA 94063
650-595-2595

Atreca, Inc. discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechani® of action and target derived from an antibody identified using its discovery platform. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues.

Data derived from most recent annual or quarterly report
Market Cap 8.307 Million Shares Outstanding37.76 Million Avg 30-day Volume 571.345 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.49
Price to Revenue0.0 Debt to Equity0.0 EBITDA-79.514 Million
Price to Book Value0.859 Operating Margin0.0 Enterprise Value-161.548 Thousand
Current Ratio3.495 EPS Growth0.248 Quick Ratio3.209
1 Yr BETA 2.0054 52-week High/Low 2.05 / 0.19 Profit Margin0.0
Operating Cash Flow Growth20.7999 Free Cash Flow to Firm (FCFF) TTM -53.096 Million Free Cash Flow to Equity (FCFE) TTM-60.918 Million
Altman Z-Score-7.8836
Earnings Report2024-02-29
View SEC Filings from BCEL instead.

View recent insider trading info

Atreca Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BCEL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BCEL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2023-09-27 by RUIZ ROGER RICHARD
  • 4: filed on 2023-08-04 by GOULD STEPHEN E
  • 4: filed on 2023-08-04 by COURTNEY PHILLIPS
  • 4: filed on 2023-06-15 by ROLFE LINDSEY
  • 4: filed on 2023-06-15 by ROBINSON WILLIAM HEWITT
  • 4: filed on 2023-06-15 by MA STACEY
  • 4: filed on 2023-06-15 by LACEY DAVID L.
  • 4: filed on 2023-06-15 by BRADY STEPHEN R
  • 4: filed on 2023-01-11 by BISHOP PHILIPPE C
  • 3: filed on 2023-01-11 by BISHOP PHILIPPE C

    • Events (8k)

  • 8-K: filed on 2023-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-21:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-14:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-15:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-01:
    Item 2.05: Cost Associated with Exit or Disposal Activities

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    274.7 Thousand total shares from 2 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BAKER BROS. ADVISORS LP

    BAKER JULIAN

    BAKER FELIX

    BAKER BROS. ADVISORS (GP) LLC

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 3,258,021 2023-10-19 1

    RUIZ ROGER RICHARD VP OF FINANCE

    • Officer
    		 34,980 2023-09-17 1

    CROSS HERB CHIEF FINANCIAL OFFICER

    • Officer
    		 72,817 2023-08-02 2

    SERAFINI TITO CHIEF STRATEGY OFFICER

    • Officer
    • Director
    		 351,692 2023-08-02 2

    COURTNEY PHILLIPS GENERAL COUNSEL & SECRETARY

    • Officer
    		 57,492 2023-08-02 2

    GOULD STEPHEN E CHIEF SCIENTIFIC OFFICER

    • Officer
    		 28,424 2023-08-02 2

    BALL KRISTINE M

    • Director
    		 0 2023-06-13 1

    ATWOOD BRIAN G

    • Director
    		 0 2023-06-13 1

    BERGER FRANKLIN M

    • Director
    		 0 2023-06-13 1

    BRADY STEPHEN R

    • Director
    		 0 2023-06-13 1

    ROLFE LINDSEY

    • Director
    		 0 2023-06-13 1

    LACEY DAVID L.

    • Director
    		 0 2023-06-13 1

    ROBINSON WILLIAM HEWITT

    • Director
    		 0 2023-06-13 1

    MA STACEY

    • Director
    		 0 2023-06-13 1

    ORWIN JOHN A PRESIDENT & CEO

    • Officer
    • Director
    		 100,492 2023-02-09 1

    BISHOP PHILIPPE C CHIEF MEDICAL OFFICER

    • Officer
    		 0 2023-01-09 2

    GREENBERG NORMAN MICHAEL CHIEF SCIENTIFIC OFFICER

    • Officer
    		 41,928 2021-03-17 0

    DECKER LISA LYNN CHIEF BUSINESS OFFICER

    • Officer
    		 0 2021-01-27 0

    CAVET GUY CHIEF TECHNICAL OFFICER

    • Officer
    		 87,758 2020-02-25 0

    STEINMAN LAWRENCE

    • Director
    		 258,405 2019-06-24 0

    REDMILE GROUP, LLC

    GREEN JEREMY

    • 10% Owner
    		 No longer subject to file 2019-06-24 0

    BILL & MELINDA GATES FOUNDATION

    • 10% Owner
    		 0 2019-06-24 0

    HADLEY HARBOR MASTER INVESTORS (CAYMAN) II L.P.

    • 10% Owner
    		 No longer subject to file 2019-06-24 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BAKER BROS. ADVISORS LP FORMER 10% OWNER see footnotes

    BAKER JULIAN FORMER 10% OWNER see footnotes

    BAKER FELIX FORMER 10% OWNER see footnotes

    BAKER BROS. ADVISORS (GP) LLC FORMER 10% OWNER see footnotes

    		2023-10-23 16:49:08 -0400 2023-10-19 S 22,837 $0.40 d 286,893 indirect

    BAKER BROS. ADVISORS LP FORMER 10% OWNER see footnotes

    BAKER JULIAN FORMER 10% OWNER see footnotes

    BAKER FELIX FORMER 10% OWNER see footnotes

    BAKER BROS. ADVISORS (GP) LLC FORMER 10% OWNER see footnotes

    		2023-10-23 16:49:08 -0400 2023-10-19 S 251,902 $0.40 d 2,971,128 indirect

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ATRECA INC - A BCEL 2023-12-01 16:45:03 UTC -53.5803 58.9003 700000
    ATRECA INC - A BCEL 2023-12-01 16:15:04 UTC -53.5803 58.9003 700000
    ATRECA INC - A BCEL 2023-12-01 15:45:03 UTC -53.5803 58.9003 700000
    ATRECA INC - A BCEL 2023-12-01 15:15:05 UTC -53.5803 58.9003 700000
    ATRECA INC - A BCEL 2023-12-01 14:45:03 UTC -53.5803 58.9003 700000
    ATRECA INC - A BCEL 2023-12-01 14:15:04 UTC -53.5803 58.9003 700000
    ATRECA INC - A BCEL 2023-12-01 13:45:04 UTC -46.8582 52.1782 700000
    ATRECA INC - A BCEL 2023-12-01 13:15:04 UTC -46.8582 52.1782 450000
    ATRECA INC - A BCEL 2023-12-01 12:45:04 UTC -46.8582 52.1782 450000
    ATRECA INC - A BCEL 2023-11-30 22:15:04 UTC -48.2839 53.6039 750000
    ATRECA INC - A BCEL 2023-11-30 21:45:04 UTC -48.2839 53.6039 750000
    ATRECA INC - A BCEL 2023-11-30 21:15:05 UTC -48.2839 53.6039 750000
    ATRECA INC - A BCEL 2023-11-30 20:45:05 UTC -48.2839 53.6039 750000
    ATRECA INC - A BCEL 2023-11-30 20:16:16 UTC -48.9826 54.3026 750000
    ATRECA INC - A BCEL 2023-11-30 19:45:03 UTC -48.9826 54.3026 750000
    ATRECA INC - A BCEL 2023-11-30 19:15:04 UTC -48.9826 54.3026 750000
    ATRECA INC - A BCEL 2023-11-30 18:45:04 UTC -48.9826 54.3026 750000
    ATRECA INC - A BCEL 2023-11-30 18:15:04 UTC -48.9826 54.3026 750000
    ATRECA INC - A BCEL 2023-11-30 17:45:04 UTC -48.9826 54.3026 750000
    ATRECA INC - A BCEL 2023-11-30 17:15:04 UTC -48.9826 54.3026 750000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund BCEL -29.0 shares, $-479.95 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund BCEL -1.0 shares, $-16.55 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund BCEL -42.0 shares, $-695.1 2020-03-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BCEL -2500.0 shares, $-652.51 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments